Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY3113593 in Healthy Subjects and CKD Patients on Hemodialysis
NCT02144285Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2014
- Primary completion
- Aug 2015
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of LY3113593 in anemia of chronic kidney disease (CKD-A), sponsored by Eli Lilly and Company. Started Jun 2014; status: completed.
02
Drugs
LY3113593
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02144285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144285.